Chlamydia Pneumoniae Infection

Luigi Allegra, Francesco Blasi (Autoren)

Buch | Softcover

VIII, 90 Seiten

1995 | 1. Softcover reprint of the original 1st ed. 1995
Springer Berlin (Verlag)
978-3-540-75007-9 (ISBN)

Infos

A flood of data indicate the importance and the relevance in both respiratory and extrapulmonary disease of Chlamydia pneumoniae infection today. Antibody prevalence rates in Western countries reach 50% in the adult population and remain high in old age suggesting a high rate of reinfection. Chlamydia pneumoniae can cause upper respiratory tract infections, like pharyngitis and sinusitis as well as bronchitis and more than 10% of community-acquired pneumonia. Recent data suggest a possible association of Chlamydia pneumoniae infection with wheezing and adult-onset asthma. However, the most intriguing hypothesis pertains the possible association between Chlamydia pneumoniae infection and atherosclerosis.

Inhalt

1 History of a New Agent of Pneumonia.- 2 Chlamydia pneumoniae Microbiology.- 3 Laboratory Diagnosis.- 4 Epidemiology.- 5 Pharmacological and Pharmacokinetic Basis of Chlamydia pneumoniae Treatment.- 6 Clinical Characteristics of Chlamydia pneumoniae Infection.- 7 Immunology of Chlamydia pneumoniae.- 8 Chronic Chlamydia pneumoniae Infections.- 9 Evidence for Chlamydia pneumoniae Infection in Asthma.- 10 Chlamydia pneumoniae Pneumonia: Radiological Features.- 11 Perspectives and Perceptions on the Clinical Relevance of Chlamydia pneumoniae Infection.

Produkt-Details

• Erscheint lt. Verlag: 8.8.1995
• Zusatzinfo: VIII, 90 p.
• Verlagsort: Milano
• Sprache: englisch
• Maße: 155 x 235 mm
• Gewicht: 205 g
• Themenwelt: Medizinische Fachgebiete ► Innere Medizin ► Pneumologie
• Schlagworte: Age • Antibody • Asthma • atherosclerosis • Biology • Breathing • Diagnosis • epidemiology • Infection • Infections • Laboratory • Microbiology • Pharmacokinetics • pharmacology • Treatment
• ISBN-10: 3-540-75007-X / 354075007X
• ISBN-13: 978-3-540-75007-9 / 9783540750079
• Zustand: Neuware